1 | Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in KrasG12D-driven tumors. (Santofimia-Castaño P, Fraunhoffer N, Liu X, Bessone IF, di Magliano MP, Audebert S, Camoin L, Estaras M, Brenière M, Modesti M, Lomberk G, Urrutia R, Soubeyran P, Neira JL, Iovanna J) EMBO Mol Med 2024 Mar;16(3):475-505 3 Citations |
1 | Adherence to Surveillance Endoscopies Posteradication of Barrett's Esophagus With High-grade Dysplasia or Carcinoma In Situ. (Um PS, Chan MQ, Hinton A, Haisley K, Perry KA, Balasubramanian G) J Clin Gastroenterol 2023 May-Jun 01;57(5):459-465 1 Citation |
2 | Keratin 7 and ERBB2 Negative Mammary Paget Disease Without an Underlying in Situ and Invasive Carcinoma. (Ratiani M, Farooq A, Jorns J, Sheinin Y) Int J Surg Pathol 2022 Aug;30(5):590-592 1 Citation |
1 | Prevention and control of neoplasms associated with HPV in high-risk groups in Mexico City: The Condesa Study. (Lazcano-Ponce E, Salmerón J, González A, Allen-Leigh B, León-Maldonado L, Magis C, Aranda-Flores C, Conde-González C, Portillo-Romero AJ, Yunes-Díaz E, Rivera-Rivera L, Vargas G, Nyitray AG, Giuliano AR) Salud Publica Mex 2018;60(6):703-712 9 Citations |
4 | Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 5 Citations |
1 | Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness. (Deshmukh AA, Chiao EY, Cantor SB, Stier EA, Goldstone SE, Nyitray AG, Wilkin T, Wang X, Chhatwal J) Cancer 2017 Dec 01;123(23):4709-4719 27 Citations |
1 | Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. (Fox RG, Lytle NK, Jaquish DV, Park FD, Ito T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp J, Kritzik M, Sicklick J, Sander M, Grandgenett PM, Hollingsworth MA, Shibata S, Pizzo D, Valasek M, Sasik R, Scadeng M, Okano H, Kim Y, MacLeod AR, Lowy AM, Reya T) Nature 2016 Jun 16;534(7607):407-411 115 Citations |
1 | Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men. (Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB) Clin Infect Dis 2015 Nov 15;61(10):1527-35 46 Citations |
1 | Lobular neoplasia: morphology and management. (Jorns J, Sabel MS, Pang JC) Arch Pathol Lab Med 2014 Oct;138(10):1344-9 19 Citations |
2 | IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation. (Garcia MN, Grasso D, Lopez-Millan MB, Hamidi T, Loncle C, Tomasini R, Lomberk G, Porteu F, Urrutia R, Iovanna JL) J Clin Invest 2014 Nov;124(11):4709-22 37 Citations |
1 | Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. (Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD) Am J Obstet Gynecol 2014 Apr;210(4):366.e1-366.e5 28 Citations |
1 | Intraepithelial sebaceous carcinoma: a case report of an unusual occurrence. (Currie GP, Plaza JA, Harris GJ) Am J Dermatopathol 2014 Aug;36(8):673-6 14 Citations |
1 | Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. (Ma D, Hovey RL, Zhang Z, Fye S, Huettner PC, Borecki IB, Rader JS) Gynecol Oncol 2013 Nov;131(2):445-50 10 Citations |
1 | PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. (Ludwig K, Fassan M, Mescoli C, Pizzi M, Balistreri M, Albertoni L, Pucciarelli S, Scarpa M, Sturniolo GC, Angriman I, Rugge M) Virchows Arch 2013 Jan;462(1):57-63 57 Citations |
1 | Neosquamous epithelium after ablation of Barrett's epithelium: cause for concern? (Dua KS, Merrill J, Komorowski R) Gastrointest Endosc 2012 Nov;76(5):1082-3 2 Citations |
1 | Alveolar variant of invasive lobular carcinoma in a fibroadenoma. (Butler R, Pinsky R, Jorns JM) Breast J 2012;18(6):613-4 3 Citations |
1 | Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 53 Citations |
1 | Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. (Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC) J Clin Oncol 2007 Aug 01;25(22):3251-8 45 Citations |
1 | The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. (Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GV) Breast J 2006;12(3):212-5 3 Citations |
1 | Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. (Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM) J Am Coll Surg 2005 Apr;200(4):516-26 264 Citations |
1 | Intravesical valrubicin in the treatment of carcinoma in situ of the bladder. (Kuznetsov DD, Alsikafi NF, O'Connor RC, Steinberg GD) Expert Opin Pharmacother 2001 Jun;2(6):1009-13 22 Citations |
1 | p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. (Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC) Am J Surg Pathol 1998 Dec;22(12):1463-73 88 Citations |
1 | Parity, age at first birth and the risk of carcinoma in situ of the breast. (Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO) Int J Cancer 1998 Jul 29;77(3):330-2 38 Citations |
1 | Microsatellite instability in in situ and invasive sporadic breast cancers of Japanese women. (Toyama T, Iwase H, Iwata H, Hara Y, Omoto Y, Suchi M, Kato T, Nakamura T, Kobayashi S) Cancer Lett 1996 Nov 29;108(2):205-9 21 Citations |
1 | The mons pubis: an excellent graft donor site in gynecologic surgery. (Dudzinski MR, Rader JS) Am J Obstet Gynecol 1990 Mar;162(3):722-5 1 Citation |